Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

被引：0
|
作者：
Patrick J. van der Geest
Nicole G. M. Hunfeld
Sophie E. Ladage
A. B. Johan Groeneveld
机构：
[1] Erasmus University Medical Center,Department of Intensive Care Medicine
[2] Erasmus University Medical Center,Department of Pharmacy
来源：
BMC Infectious Diseases | / 16卷
关键词：
Critically ill; Micafungin; Anidulafungin; Invasive candidiasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
    van der Geest, Patrick J.
    Hunfeld, Nicole G. M.
    Ladage, Sophie E.
    Groeneveld, A. B. Johan
    BMC INFECTIOUS DISEASES, 2016, 16
  • [2] Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
    Boonstra, J. M.
    van der Elst, K. C.
    Veringa, A.
    Jongedijk, E. M.
    Bruggemann, R. J.
    Koster, R. A.
    Kampinga, G. A.
    Kosterink, J. G.
    van der Werf, T. S.
    Zijlstra, J. G.
    Touw, D. J.
    Alffenaar, J. W. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [3] Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
    Liu, Ping
    Ruhnke, Markus
    Meersseman, Wouter
    Paiva, Jose Artur
    Kantecki, Michal
    Damle, Bharat
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1672 - 1676
  • [4] Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
    Ruhnke, M.
    Paiva, J. A.
    Meersseman, W.
    Pachl, J.
    Grigoras, I.
    Sganga, G.
    Menichetti, F.
    Montravers, P.
    Auzinger, G.
    Dimopoulos, G.
    Borges Sa, M.
    Miller, P. J.
    Marcek, T.
    Kantecki, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) : 680 - 687
  • [5] Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasis
    Elkayal, Omar
    Hoffert, Yannick
    Mertens, Beatrijs
    Van Daele, Ruth
    Lagrou, Katrien
    Wauters, Joost
    Spriet, Isabel
    Dreesen, Erwin
    INFECTION, 2024, : 1155 - 1165
  • [6] Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study
    Hasan, Md Jahidul
    Neelotpol, Sharmind
    Rabbani, Raihan
    JOURNAL OF CRITICAL CARE MEDICINE, 2022, 8 (02) : 89 - 99
  • [7] Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
    Boonstra, J. M.
    van der Elst, K. C.
    Zijlstra, J. G.
    van der Werf, T. S.
    Alffenaar, J. W. C.
    Touw, D. J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [8] Invasive candidiasis in critically ill patients
    Kaaniche, Fatma Medhioub
    Allela, Rania
    Cherif, Samar
    ben Algia, Najla
    TRENDS IN ANAESTHESIA AND CRITICAL CARE, 2016, 11 : 1 - 5
  • [9] Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
    Suh, Jin Woong
    Kim, Sun Bean
    Yoon, Young Kyung
    Sohn, Jang Wook
    Kim, Min Ja
    Kim, Jong Hun
    MYCOPATHOLOGIA, 2020, 185 (04) : 653 - 664
  • [10] Anidulafungin in the treatment of patients with invasive candidiasis
    Kett, Daniel H.
    Cubillos, G. Fernando
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S99 - S102
12345